Nanomechanical Characterization of Ovarian Cancer Cell Lines as a Marker of Response to 2c Treatment

Int J Mol Sci. 2023 Apr 13;24(8):7230. doi: 10.3390/ijms24087230.

Abstract

Epithelial ovarian cancers (EOCs) are a heterogeneous group of tumors with different molecular and clinical features. In past decades, few improvements have been achieved in terms of EOC management and treatment efficacy, such that the 5-year survival rate of patients remained almost unchanged. A better characterization of EOCs' heterogeneity is needed to identify cancer vulnerabilities, stratify patients and adopt proper therapies. The mechanical features of malignant cells are emerging as new biomarkers of cancer invasiveness and drug resistance that can further improve our knowledge of EOC biology and allow the identification of new molecular targets. In this study, we determined the inter and intra-mechanical heterogeneity of eight ovarian cancer cell lines and their association with tumor invasiveness and resistance to an anti-tumoral drug with cytoskeleton depolymerization activity (2c).

Keywords: 2c; AFM; heterogeneity; invasiveness; ovarian cancer cell lines; resistance; stiffness.

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Carcinoma, Ovarian Epithelial / drug therapy
  • Cell Line, Tumor
  • Female
  • Humans
  • Neoplasms, Glandular and Epithelial* / drug therapy
  • Ovarian Neoplasms* / metabolism

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor